These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32578212)

  • 1. Emergence of lymphomatoid papulosis during treatment with brentuximab vedotin.
    Mansoor N; McKenna L; Molloy O; Smyth E; Flavin R; Ryan C; Quinn J; Roche M
    Int J Dermatol; 2020 Sep; 59(9):e332-e334. PubMed ID: 32578212
    [No Abstract]   [Full Text] [Related]  

  • 2. Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results.
    Lewis DJ; Talpur R; Huen AO; Tetzlaff MT; Duvic M
    JAMA Dermatol; 2017 Dec; 153(12):1302-1306. PubMed ID: 28980004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare case of early-onset lymphomatoid papulosis refractory to brentuximab vedotin.
    Ferranti M; Salmaso R; Marino D; Alaibac M
    Dermatol Ther; 2021 May; 34(3):e14943. PubMed ID: 33719147
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphomatoid papulosis and fingolimod-A new connection?
    Cohen V; Saber M; Provost N; Friedmann D
    Mult Scler; 2016 Oct; 22(12):1629-1630. PubMed ID: 26993118
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
    Samaraweera AP; Cohen SN; Akay EM; Evangelou N
    Mult Scler; 2016 Jan; 22(1):122-4. PubMed ID: 26219664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tattoos and coincidental skin conditions: the example of lymphomatoid papulosis.
    Kluger N
    Br J Dermatol; 2014 Dec; 171(6):1561. PubMed ID: 24841722
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphomatoid papulosis and FK 506.
    Siddiqui MA; Sullivan S; al-Mofadhi AM
    Int J Dermatol; 1997 Mar; 36(3):202-5. PubMed ID: 9159004
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
    Matoula T; Nikolaou V; Marinos L; Katsavos S; Nasis G; Economidi A; Karampidou K; Stratigos A; Antoniou C
    Mult Scler; 2016 Oct; 22(12):1630-1631. PubMed ID: 27053634
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
    Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
    J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum responding to ciclosporin without adverse effects in a patient with lymphomatoid papulosis.
    Busick TL; Bennett DD; Cohen JB
    Clin Exp Dermatol; 2010 Dec; 35(8):918-9. PubMed ID: 20456406
    [No Abstract]   [Full Text] [Related]  

  • 11. CD30-positive lymphoproliferative disorder in a red tattoo: regional lymphomatoid papulosis type C or pseudolymphoma?
    Haus G; Utikal J; Geraud C; Goerdt S; Leverkus M
    Br J Dermatol; 2014 Sep; 171(3):668-70. PubMed ID: 24689991
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.
    Park JH; Lee J; Lee JH; Lee DY; Koh EM
    Dermatology; 2012; 225(3):259-63. PubMed ID: 23257839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of mycosis fungoide : focus on brentuximab vedotin].
    Lebas E; Collins P; Bonnet C; Libon F; Dezfoulian B; Nikkels AF
    Rev Med Liege; 2021 Apr; 76(4):224-231. PubMed ID: 33830684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
    Trager MH; Chen C; Husain S; Geskin LJ
    J Dermatol; 2020 May; 47(5):546-550. PubMed ID: 32100361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolic acid for lymphomatoid papulosis.
    Champagne T; Walsh S
    J Cutan Med Surg; 2013; 17(5):332-4. PubMed ID: 24067853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study.
    Dummer R; Prince HM; Whittaker S; Horwitz SM; Kim YH; Scarisbrick J; Quaglino P; Zinzani PL; Wolter P; Eradat H; Pinter-Brown L; Sanches JA; Ortiz-Romero PL; Akilov OE; Geskin L; Huen A; Walewski J; Wang Y; Lisano J; Richhariya A; Feliciano J; Zhu Y; Bunn V; Little M; Zagadailov E; Dalal MR; Duvic M
    Eur J Cancer; 2020 Jul; 133():120-130. PubMed ID: 32502876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of lymphomatoid papulosis type E with extensive necrosis.
    Pindado-Ortega C; Fonda-Pascual P; Buendía-Castaño D; Fernández-González P; Peña-Jaimes L; Carrillo-Gijón R
    Indian J Dermatol Venereol Leprol; 2018; 84(4):515-517. PubMed ID: 29067932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphomatoid papulosis.
    Wiznia LE; Cohen JM; Beasley JM; Meehan SA; Latkowski JM
    Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type A lymphomatoid papulosis presenting as an eyelid ulcer in a young man.
    Sánchez España JC; Secondi R
    Orbit; 2019 Dec; 38(6):495-499. PubMed ID: 30644803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotin.
    Goyal A; Patel S; Goyal K; Morgan EA; Foreman RK
    J Cutan Pathol; 2019 Nov; 46(11):823-829. PubMed ID: 31286556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.